[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100580671":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":10,"centralContacts":24,"locations":31,"responsibleParty":47,"collaborators":10,"id":49,"slug":10,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":65,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"University Hospital, Toulouse","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Scheduled cardiac surgery patients",null,"Scheduled cardiac surgery patients undergoing bypass surgery with saphenous vein harvesting.",[13,14],"Other: Blood and tissue samples","Other: walking test",[16,20],{"type":6,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"Blood and tissue samples","Blood samples will be taken from catheters placed for the purpose of surgery (arterial and venous catheters), or during routine venipunctures. (D-1 pre-op). Tissue samples will be taken from surgical waste generated by the surgery. They will therefore not require any additional incisions or surgical procedures.",[9],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"walking test","The study includes a walking test between D5 and D7.",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"François LABASTE, MD-PH","CONTACT","05 61 32 28 22","+33","labaste.f@chu-toulouse.fr",[32],{"facility":33,"status":34,"city":35,"state":10,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"UHToulouse","RECRUITING","Toulouse","France","FR",{"type":39,"coordinates":40},"Point",[41,42],1.44367,43.60426,{"lat":42,"lon":41},[45],{"name":46,"role":27,"phone":10,"phoneExt":10,"email":10},"François LABASTE, MCU-PH",{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100580671",false,"NCT06840327","Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome","VARIOXY","Inclusion Criteria:\n\nPatients over 18 years of age Scheduled cardiac surgery patients undergoing bypass surgery with saphenous vein harvesting.\n\nPatients able to understand the protocol; Patients able to express non-opposition to participating in the study Patients affiliated to a social security system or equivalent.\n\nExclusion Criteria:\n\nEmergency surgery patients. Pregnant or breast-feeding women. Patients deprived of their freedom or under legal protective measures.","ALL","18 Years",{"count":58,"type":59},120,"ESTIMATED","OBSERVATIONAL","Observational, prospective, monocentric study conducted in the cardiac surgery department about biological markers to predict the short-term outcome of heart surgery patients.",[63,64],"Cardiac Surgery","Extracorporeal Circulation",[66,67,68,69,70],"extracorporeal circulation","cardiac surgery","biological markers","Redox balance","post-operative outcome","2026-06-24",{"date":73,"type":74},"2026-06-29","ACTUAL",{"date":76,"type":74},"2025-10-07",{"date":78,"type":59},"2027-10",{"name":5,"class":6},1]